GLP-1 (the "un-hunger hormone") is released in response to nutrients in your gut.* GLP-1 enters the bloodstream and interacts with organs, mainly the pancreas.* GLP-1 binds to pancreatic cells, promoting insulin release and impacting appetite and digestion.* GLP-1 helps you feel full and supports glucose metabolism
Reflecting a growing acceptance of obesity as a legitimate medical condition, at least in the United State, a 2024 employer health benefits survey found that 61% of respondents support expanding Medicare (federal health insurance program primarily for individuals aged 65 and older) coverage beyond treatment for T2DM to include GLP-1 therapies for weight management in overweight individuals (Kaiser Family, F, 2024)
doi: 10.1200/JCO.2012.44.8738 [DOI] [PMC free article] [PubMed] [Google Scholar] 38.Campone M, Berton-Rigaud D, Joly-Lobbedez F, et al
However, it can be a valuable complementary approach for metabolic health, especially for people focused on prevention rather than treatment of existing conditions
Gradual Results: Peptide therapy is not a quick fix